The revised staging system provides a detailed common nomenclature and more clearly defines the prognosis for patients with NSCLC through the addition of many new patient subgroups and ...

A 14-gene molecular assay may help identify early-stage non-squamous NSCLC patients who benefit from chemotherapy ...

One way to describe NSCLC is by its clinical or pathologic stage. Your doctor might use imaging scans to take pictures of the inside of your body to see what clinical stage the cancer is.

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Significant upstaging or reclassification to a more advanced stage due to cancer progression in non-small cell lung cancer (NSCLC) can occur with each successive week from initial clinical staging ...

July 17, 2012 — A thorough lymph node examination can enhance the detection of unexpected metastatic disease in patients with nonsmall-cell lung cancer (NSCLC), but current practices are ...

The phase 3 LUSTRE trial, which compared SBRT vs hypofractionated conventional radiotherapy, enrolled 233 patients (mean age, 75.4 years) with medically inoperable stage T1/T2aN0M0 NSCLC across 16 ...

Please provide your email address to receive an email when new articles are posted on . The use of a staging approach that combined endosonography and surgical staging for patients with suspected ...

The revised staging system provides a detailed common nomenclature and more clearly defines the prognosis for patients with NSCLC through the addition of many new patient subgroups and ...